Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Weller, Karsten
- dc.contributor.author Ohanyan, Tatevik
- dc.contributor.author Hawro, Tomasz
- dc.contributor.author Ellrich, André
- dc.contributor.author Sussman, Gordon
- dc.contributor.author Koplowitz, Jake
- dc.contributor.author Giménez Arnau, Anna Maria
- dc.contributor.author Peveling-Oberhag, Adriane
- dc.contributor.author Staubach, Petra
- dc.contributor.author Metz, Martin
- dc.contributor.author Maurer, Marcus
- dc.date.accessioned 2019-02-20T09:08:56Z
- dc.date.issued 2018
- dc.format.mimetype application/pdf
- dc.identifier.citation Weller K, Ohanyan T, Hawro T, Ellrich A, Sussman G, Koplowitz J. et al. Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab. Allergy. 2018 Dec;73(12):2406-2408. DOI: 10.1111/all.13586
- dc.identifier.doi http://dx.doi.org/10.1111/all.13586
- dc.identifier.issn 0105-4538
- dc.identifier.uri http://hdl.handle.net/10230/36634
- dc.language.iso eng
- dc.publisher Wiley-Blackwell
- dc.rights This is the pre-peer reviewed version of the following article: Weller K, Ohanyan T, Hawro T, Ellrich A, Sussman G, Koplowitz J. et al. Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab. Allergy. 2018 Dec;73(12):2406-2408, which has been published in final form at http://dx.doi.org/10.1111/all.13586. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.other Urticària -- Tractament
- dc.title Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion